Rapid Dose Therapeutics Ratios and Metrics

Market cap in millions CAD. Fiscal year is March - February.

Millions CAD. Fiscal year is Mar - Feb.

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug '26 Aug 7, 2026	Feb '26 Feb 28, 2026	Feb '25 Feb 28, 2025	Feb '24 Feb 29, 2024	Feb '23 Feb 28, 2023	Feb '22 Feb 28, 2022
Market Capitalization	12	20	22	21	9	26
Market Cap Growth	-47.19%	-7.92%	6.81%	121.17%	-64.76%	56.16%
Enterprise Value	18	26	25	23	11	28
Last Close Price	0.09	0.15	0.17	0.17	0.09	0.26
PS Ratio	4.77	7.31	10.56	20.20	12.98	15.10
PB Ratio	-1.63	-2.83	-4.23	-6.53	-3.49	105.16
P/TBV Ratio	-	-	-	-	-	105.16
EV/Sales Ratio	7.02	9.53	11.79	23.00	15.75	15.81
Debt / Equity Ratio	-0.77	-0.74	-0.50	-0.78	-0.79	5.70
Net Debt / Equity Ratio	-0.77	-0.74	-0.50	-0.73	-0.78	5.56
Net Debt / EBITDA Ratio	-3.18	-2.65	-0.65	-0.83	-0.65	-0.37
Net Debt / FCF Ratio	27.49	-19.57	-2.25	-1.00	-2.43	-0.46
Asset Turnover	0.72	1.13	1.19	0.49	0.27	0.51
Inventory Turnover	6.09	6.78	4.25	2.79	1.67	1.26
Quick Ratio	0.02	0.02	0.05	0.13	0.04	0.09
Current Ratio	0.04	0.04	0.10	0.23	0.09	0.25
Return on Assets (ROA)	-33.30%	-55.19%	-148.14%	-93.37%	-83.34%	-77.93%
Return on Capital Employed (ROCE)	33.90%	42.10%	80.10%	298.70%	134.20%	-698.60%
Earnings Yield	-25.81%	-16.72%	-24.54%	-20.89%	-40.87%	-32.08%
FCF Yield	1.72%	-1.34%	-5.23%	-11.13%	-9.27%	-11.49%
Buyback Yield / Dilution	-5.68%	-6.73%	-18.68%	-1.50%	-3.19%	-28.83%